On The Pen Launches Redesigned GLP-1 News Website as Independent Media Platform Expands

"Dave Knapp, founder and CEO of On The Pen announces a redesigned GLP-1 news website, expanding its independent coverage of obesity medicine, diabetes, metabolic health and the pharmaceutical industry."On The Pen has launched a redesigned OnThePen.com, strengthening its position as a destination for GLP-1 news, obesity medicine coverage and patient-centered reporting. The platform is also home to On The Pen: The Weekly Dose Podcast, a top-ranked, award-winning GLP-1 podcast in the top 0.5% of all podcasts globally.

CEDAR FALLS, Iowa - September 15, 2026 - On The Pen, an independent GLP-1 news and media platform covering obesity medicine, diabetes, metabolic health and the pharmaceutical industry, has launched a redesigned version of OnThePen.com.

The refresh gives On The Pen a cleaner, more traditional digital newsroom with improved navigation, stronger breaking-news presentation and easier access to written reporting, podcasts, livestreams and video coverage.

The redesigned site expands On The Pen’s role as a destination for top-ranked GLP-1 news, including coverage of Ozempic, Wegovy, Mounjaro, Zepbound, retatrutide, clinical trials, drug pricing, access, insurance, telehealth, compounding and pharmaceutical industry developments.

“On The Pen started because there was a deficit of information that actually spoke to them,” said founder Dave Knapp. “The new site gives that reporting a stronger home and makes it easier for people to understand what is happening in GLP-1 medicine and what it could mean for them.”

The website also gives greater prominence to On The Pen: The Weekly Dose Podcast, a top-ranked, award-winning GLP-1 podcast in the top 0.5% of all podcasts globally.

Together, the website, podcast and live programming position On The Pen as an independent multimedia source for GLP-1 news, obesity medicine coverage and patient-centered reporting.

About On The Pen

On The Pen is an independent GLP-1 news and media platform covering GLP-1 medications, obesity medicine, diabetes, metabolic health and the pharmaceutical industry. The platform publishes breaking GLP-1 news, original reporting, analysis, livestreams and On The Pen: The Weekly Dose Podcast. Its mission is to empower patients to have better conversations with their doctors.

Media Contact

Company Name:OTP MEDIA CORP

Contact Person: Ann.Metz

Email:Send Email

Phone: 3193000840

Address:3045 Capital Way #5 Stge 201-G

City: Cedar Falls

State: IA

Country: United States

Website:www.onthepen.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: On The Pen Launches Redesigned GLP-1 News Website as Independent Media Platform Expands

Media gallery